Archive: neuroscience
-
Brain Studies Show Chronic Fatigue Syndrome and Gulf War Illness are Distinct Conditions
CHICAGO (October 23, 2019) — Gulf War Illness (GWI) and chronic fatigue syndrome (CFS) share symptoms of disabling fatigue, pain, systemic hyperalgesia (tenderness), negative emotion, sleep and cognitive dysfunction that are made worse after mild exertion (postexertional malaise). Now, neuroscientists at Georgetown University Medical Center have evidence, derived from human brain studies, that GWI and […]
Category: News Release
-
Why, Sometimes, We Don’t See What We Actually Saw
WASHINGTON (October 23, 2019) — Georgetown neuroscientists say they have identified how people can have a “crash in visual processing” — a bottleneck of feedforward and feedback signals that can cause us not to be consciously aware of stimuli that our brain recognized. In the Journal of Vision (DOI 10.1167/19.12.20), investigators describe what can occur […]
Category: News Release
-
Novel Agent Flips on ‘Garbage Disposal’ in Neurons, Eliminating Toxic Brain Proteins in Mice
CHICAGO (October 22, 2019) — Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson’s and Alzheimer’s diseases, and improves cognitive and motor behavior. The team presented their findings about the agent, CM101 (also known as BK40143), in […]
Category: News Release
-
Exposure to Environmental PCBs Impairs Brain Function in Mice
CHICAGO (October 22, 2019) — Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center. Their study, believed to be the first to test polychlorinated biphenyls (PCBs) in astrocytes — cells […]
Category: News Release
-
Finding Upends Theory about the Cerebellum’s Role in Reading and Dyslexia
WASHINGTON (October 9, 2019) — New brain imaging research debunks a controversial theory about dyslexia that can impact how it is sometimes treated, Georgetown University Medical Center neuroscientists say. The cerebellum, a brain structure traditionally considered to be involved in motor function, has been implicated in the reading disability known as developmental dyslexia. However, this […]
Category: News Release
-
Celebrating National Postdoc Appreciation Week
Reiko Asano, PhD, RN Reiko Asano, PhD, RN, is a postdoc in the department of professional nursing practice studying palliative care in heart failure. Reiko was inspired to study cardiovascular disease after caring for patients suffering from high symptom burden and repeated hospitalizations. Alexandra Taraboletti, PhD Georgetown Lombardi Comprehensive Cancer Center’s Alexandra Taraboletti, PhD, is […]
Category: GUMC Stories
-
Maguire-Zeiss Named New Chair of Department of Neuroscience
(August 29, 2019) — Since joining Georgetown’s faculty in 2007, Kathy Maguire-Zeiss, PhD, has taken on many roles. In addition to being a professor of neuroscience, she directs the Interdisciplinary Program in Neuroscience (IPN), the Center for Neural Injury and Recovery, the master’s degree program in integrative neuroscience and the T32 Training Program in Neural […]
Category: GUMC Stories
-
Georgetown’s Memory Disorders Program Marks 20th Year
(April 12, 2019) — When President Ronald Reagan announced in 1994 that he had Alzheimer’s disease, the man known as the “great communicator” tried his best to convey a sense of optimism. “I now begin the journey that will lead me into the sunset of my life. I know that for America there will always […]
Category: GUMC Stories
-
MCGSO Welcomes Hardy Middle School During Brain Awareness Week
(March 29, 2019) — In an effort to promote brain research and awareness, the Medical Center Graduate Student Organization (MCGSO) hosted more than 100 seventh graders from a local middle school for a full day of creative, interactive brain-related activities and demonstrations. The March 14 visit to Georgetown gave MCGSO members a potent opportunity to […]
Category: GUMC Stories
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release